These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25604148)

  • 1. Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.
    Imamura T; Kinugawa K; Nitta D; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    J Artif Organs; 2015 Jun; 18(2):120-7. PubMed ID: 25604148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readmissions after continuous flow left ventricular assist device implantation.
    Kimura M; Nawata K; Kinoshita O; Yamauchi H; Hoshino Y; Hatano M; Amiya E; Kashiwa K; Endo M; Kagami Y; Nemoto M; Ono M
    J Artif Organs; 2017 Dec; 20(4):311-317. PubMed ID: 28752193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device driveline infections in three contemporary devices.
    Schlöglhofer T; Michalovics P; Riebandt J; Angleitner P; Stoiber M; Laufer G; Schima H; Wiedemann D; Zimpfer D; Moscato F
    Artif Organs; 2021 May; 45(5):464-472. PubMed ID: 33052592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present-Day Hospital Readmissions after Left Ventricular Assist Device Implantation: A Large Single-Center Study.
    Hernandez RE; Singh SK; Hoang DT; Ali SW; Elayda MA; Mallidi HR; Frazier OH; Meyers DE
    Tex Heart Inst J; 2015 Oct; 42(5):419-29. PubMed ID: 26504434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.
    Akay MH; Nathan SS; Radovancevic R; Poglajen G; Jezovnik MK; Candelaria IN; Averill BL; Patel MK; Kar B; Gregoric ID
    ASAIO J; 2019; 65(7):678-682. PubMed ID: 30398982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
    Fudim M; Brown CL; Davis ME; Djunaidi M; Danter MR; Harrell FE; Stulak JM; Haglund NA; Maltais S
    ASAIO J; 2016; 62(3):291-6. PubMed ID: 26809083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.
    Kimura Y; Seguchi O; Mochizuki H; Iwasaki K; Toda K; Kumai Y; Kuroda K; Nakajima S; Tateishi E; Watanabe T; Matsumoto Y; Fukushima S; Kiso K; Yanase M; Fujita T; Kobayashi J; Fukushima N
    J Card Fail; 2019 Oct; 25(10):795-802. PubMed ID: 31454687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device.
    Siegenthaler MP; Martin J; Pernice K; Doenst T; Sorg S; Trummer G; Friesewinkel O; Beyersdorf F
    Eur J Cardiothorac Surg; 2003 May; 23(5):748-54; discussion 754-5. PubMed ID: 12754028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation.
    Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J
    ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driveline Infection in Patients With Left Ventricular Assist Devices Implanted as Destination Therapy.
    Wasilewski G; Wiśniowska-Śmiałek S; Górkiewicz-Kot I; Milaniak I; Kaleta M; Hymczak H; Wasilewska A; Wierzbicki K
    Transplant Proc; 2024 May; 56(4):860-863. PubMed ID: 38734518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital Readmissions After Continuous-Flow Left Ventricular Assist Device Implantation: Incidence, Causes, and Cost Analysis.
    Akhter SA; Badami A; Murray M; Kohmoto T; Lozonschi L; Osaki S; Lushaj EB
    Ann Thorac Surg; 2015 Sep; 100(3):884-9. PubMed ID: 26095106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol.
    Lander MM; Kunz N; Dunn E; Althouse AD; Lockard K; Shullo MA; Kormos RL; Teuteberg JJ
    J Card Fail; 2018 Nov; 24(11):746-752. PubMed ID: 30098380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days.
    Martin SI; Wellington L; Stevenson KB; Mangino JE; Sai-Sudhakar CB; Firstenberg MS; Blais D; Sun BC
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):20-3. PubMed ID: 20388700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and Predictors of Readmissions with GI Bleeding in Patients with Left Ventricular Assist Devices.
    Shah R; Qayed E
    South Med J; 2018 Nov; 111(11):666-673. PubMed ID: 30392001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
    Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
    Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between driveline features and driveline infection in left ventricular assist device selection.
    Imamura T; Murasawa T; Kawasaki H; Kashiwa K; Kinoshita O; Nawata K; Ono M
    J Artif Organs; 2017 Mar; 20(1):34-41. PubMed ID: 27448017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
    Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
    Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
    Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.